At the news
? NEUTRALIMPACT 3/10 SC 13G filed Nov 6, 2026 at 12:35 ET
William Blair Investment Management disclosed a 5.2% passive stake in GeneDx Holdings Corp. via a new Schedule 13G filing, holding 1,560,247 shares as of September 30, 2026. The filing certifies passive intent with no control-related purpose.
- William Blair Investment Management filed a new Schedule 13G disclosing beneficial ownership of 1,560,247 shares of GeneDx Holdings Corp. common stock.
- The stake represents 5.2% of shares outstanding as of September 30, 2026.
- The filing certifies passive intent under Rule 13d-1(b), with no purpose of changing or influencing control.
- William Blair Investment Management is an investment adviser (IA) based in Chicago, IL.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access